Compliance Became
Infrastructure.
The FDA's transition to QMSR and ISO 13485-aligned enforcement reflects a broader shift toward continuous supplier verification, documentation integrity, and audit-ready procurement infrastructure.
The global medical device and institutional procurement environment is entering a new operational standard.
Regulatory harmonization, documentation accountability, supplier verification, and audit continuity are no longer isolated compliance tasks — they are now infrastructure requirements.
Institutions operating across fragmented global supply environments require systems capable of maintaining traceability, verification integrity, and execution continuity across the full procurement lifecycle.
“Institutions can no longer rely on supplier claims alone. Compliance must now be operationalized continuously.”
$1.3T
Annual global cost
of poor quality
Intellect.com
82%
Organizations reporting
supply chain disruption
McKinsey
QMSR Transition
FDA alignment with ISO 13485:2016 operational standards.
Effective February 2026
Documentation
Audit-ready traceability expectations now extend across sourcing, logistics, and fulfillment workflows.
Supplier Accountability
Verification expectations increasingly apply across the full supplier lifecycle—not only final inspection.
Execution Continuity
Institutions must maintain procurement resilience despite regulatory, geopolitical, and logistics volatility.
AGP Advantage
Our 8-Gate Quality Assurance system addresses all 69 subclauses of ISO 13485:2016 — operationalizing compliance across the full procurement lifecycle.
View 8-Gate SystemAGP operationalizes compliance continuity across the procurement lifecycle.